Works matching AU Lee, Kwan Woo


Results: 92
    1
    2
    4
    5
    6
    7

    Effects of dapagliflozin compared with glimepiride on body composition in Asian patients with type 2 diabetes inadequately controlled with metformin: The BEYOND study.

    Published in:
    Diabetes, Obesity & Metabolism, 2023, v. 25, n. 9, p. 2743, doi. 10.1111/dom.15164
    By:
    • Park, Hyeong Kyu;
    • Kim, Kyoung‐Ah;
    • Min, Kyung‐Wan;
    • Sohn, Tae‐Seo;
    • Jeong, In Kyung;
    • Ahn, Chul Woo;
    • Kim, Nan‐Hee;
    • Park, Ie Byung;
    • Cho, Ho Chan;
    • Chung, Choon Hee;
    • Choi, Sung Hee;
    • Park, Kang Seo;
    • Yang, Seoung‐Oh;
    • Lee, Kwan Woo
    Publication type:
    Article
    8

    Efficacy and safety of ipragliflozin as an add‐on therapy to sitagliptin and metformin in Korean patients with inadequately controlled type 2 diabetes mellitus: A randomized controlled trial.

    Published in:
    Diabetes, Obesity & Metabolism, 2018, v. 20, n. 10, p. 2408, doi. 10.1111/dom.13394
    By:
    • Han, Kyung‐ah;
    • Chon, Suk;
    • Chung, Choon Hee;
    • Lim, Soo;
    • Lee, Kwan‐woo;
    • Baik, Seihyun;
    • Jung, Chang Hee;
    • Kim, Dong‐sun;
    • Park, Kyong Soo;
    • Yoon, Kun‐ho;
    • Lee, In‐kyu;
    • Cha, Bong‐soo;
    • Sakatani, Taishi;
    • Park, Sumi;
    • Lee, Moon‐kyu
    Publication type:
    Article
    9
    10
    11

    Efficacy and safety of initial combination therapy with gemigliptin and metformin compared with monotherapy with either drug in patients with type 2 diabetes: A double-blind randomized controlled trial ( INICOM study).

    Published in:
    Diabetes, Obesity & Metabolism, 2017, v. 19, n. 1, p. 87, doi. 10.1111/dom.12787
    By:
    • Lim, Soo;
    • Han, Kyung Ah;
    • Yu, JaeMyung;
    • Chamnan, Parinya;
    • Kim, Eun Sook;
    • Yoon, Kun‐Ho;
    • Kwon, Sam;
    • Moon, Min Kyong;
    • Lee, Kwan Woo;
    • Kim, Dong‐Jun;
    • Kim, Mikyung;
    • Wongtanate, Manaj;
    • Kim, Eun Young;
    • Kim, Sung‐Ho;
    • Lee, Moon‐Kyu
    Publication type:
    Article
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23

    Efficacy and Safety of Voglibose Plus Metformin in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial.

    Published in:
    Diabetes & Metabolism Journal, 2019, v. 43, n. 3, p. 276, doi. 10.4093/dmj.2018.0051
    By:
    • Tae Jung Oh;
    • Jae Myung Yu;
    • Kyung Wan Min;
    • Hyun Shik Son;
    • Moon Kyu Lee;
    • Kun Ho Yoon;
    • Young Duk Song;
    • Joong Yeol Park;
    • In Kyung Jeong;
    • Bong Soo Cha;
    • Yong Seong Kim;
    • Sei Hyun Baik;
    • In Joo Kim;
    • Doo Man Kim;
    • Sung Rae Kim;
    • Kwan Woo Lee;
    • Jeong Hyung Park;
    • In Kyu Lee;
    • Tae Sun Park;
    • Sung Hee Choi
    Publication type:
    Article
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37

    Effects of rosiglitazone and metformin on inflammatory markers and adipokines: decrease in interleukin-18 is an independent factor for the improvement of homeostasis model assessment-beta in type 2 diabetes mellitus.

    Published in:
    Clinical Endocrinology, 2007, v. 66, n. 2, p. 282, doi. 10.1111/j.1365-2265.2006.02723.x
    By:
    • Kim, Hyeong Jin;
    • Kang, Eun Seok;
    • Kim, Dae Jung;
    • Kim, So Hun;
    • Ahn, Chul Woo;
    • Cha, Bong Soo;
    • Nam, Moonsuk;
    • Chung, Choon Hee;
    • Lee, Kwan Woo;
    • Nam, Chung Mo;
    • Lee, Hyun Chul
    Publication type:
    Article
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50